Bio-Rad Laboratories Inc
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California. Show More...
-
Website https://www.bio-rad.com
-
Sector Healthcare
-
Industry Medical Devices
-
Last Quote 204.60 EUR
-
Last Updated 29-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD 6.59 6.29 5.78 2.69 3.05 3.71 0.88 4.07 12.1 58.27 52.25 Dividends USD Payout Ratio % * Shares Mil 28.0 28.0 29.0 29.0 29.0 29.0 30.0 30.0 30.0 30.0 30.0 Book Value Per Share * EUR 38.66 46.38 51.29 53.68 61.61 75.75 86.44 80.11 143.87 153.35 191.59 Free Cash Flow Per Share * EUR 4.38 4.93 2.88 1.94 5.08 2.03 1.05 -0.13 4.27 8.07 Return on Assets % 6.63 5.79 5.01 2.28 2.64 3.21 0.74 3.01 7.4 25.83 20.32 Financial Leverage (Average) 1.99 1.78 1.71 1.55 1.53 1.49 1.49 1.46 1.4 1.39 1.38 Return on Equity % 13.27 10.87 8.72 3.71 4.06 4.84 1.11 4.43 10.52 35.98 28.31 Return on Invested Capital % 10.64 8.77 7.38 4.13 3.61 4.4 1.11 3.88 9.3 32.27 25.44 Interest Coverage 4.46 5.44 5.36 2.83 6.94 7.72 2.89 5.46 22.39 97.56 88.91 Current Ratio 2.96 3.92 4.11 3.59 3.84 4.03 3.91 3.93 4.49 2.41 2.4 Quick Ratio 2.12 2.64 2.81 2.12 2.41 2.67 2.57 2.43 2.74 1.66 1.63 Debt/Equity 0.48 0.42 0.36 0.2 0.2 0.17 0.17 0.15 0.11 0.03 0.03